New approach to hydrophobic cyanine-type photosensitizer delivery using polymeric oil-cored nanocarriers: Hemolytic activity, in vitro cytotoxicity and localization in cancer cells

European Journal of Pharmaceutical Sciences

Volumn 39, Issue 5, 2010, Pages 322-335

  Pietkiewicz, Jadwiga ^a   Zielińska, Katarzyna ^b   Saczko, Jolanta ^a   Kulbacka, Julita ^a   Majkowski, Michał ^c   Wilk, Kazimiera A ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^c UNIVERSITY OF WROC AW   (Poland)

Author keywords

Cyanine IR 768; Cytotoxicity; Fluorescence imaging; Hemolysis; MCF 7 cells; Photoirradiation; Poly(n butyl cyanoacrylate) nanocapsules

Indexed keywords

ENBUCRILATE; IR 768; NANOCAPSULE; NANOCARRIER; PHOTOSENSITIZING AGENT; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CELL VIABILITY; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MECHANISM; DRUG RELEASE; DRUG STRUCTURE; ENCAPSULATION; FLUORESCENCE MICROSCOPY; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; MICROEMULSION; POLYMERIZATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

CARBOCYANINES; CELL LINE, TUMOR; DRUG CARRIERS; HEMOLYSIS; HUMANS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 77549083935     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.12.012     Document Type: Article

References (67)

1. Al Khoury-Fallouh N., Roblot-Treupel L., Fessi H., Devissaguet J.P., and Puisieux F. Development of a new process for the manufacture of poly(iso-butyl cyanoacrylate) nanocapsules. Int. J. Pharm. 28 (1986) 125-136
2. Allemann E., Gurny R., and Doelker E. Drug-loaded nanoparticles-preparation methods and drug targeting issues. Eur. J. Pharm. Biopharm. 39 (1993) 173-191
3. Bae Y.H. Drug targeting and tumor heterogeneity. J. Control. Release 133 (2009) 2-3
4. Bechet D., Couleand P., Frochot C., Viriot M.L., Guillemin F., and Barbieri-Heyob M. Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol. 26 (2008) 612-621
5. Behan N., Birkinshaw C., and Clarke N. Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerisation and particle formation. Biomaterials 22 (2001) 1335-1344
6. Breunig M., Bauer S., and Goepferich A. Polymers and nanoparticles: intelligent tools for intracellular targeting. Eur. J. Pharm. Biopharm. 68 (2008) 112-128
7. Brigger I., Dubernet C., and Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 54 (2002) 631-651
8. Bumajdad A., and Eastoe J. Conductivity of water-in-oil microemulsions stabilized by mixed surfactants. J. Colloid Interface Sci. 274 (2004) 268-276
9. Castano A.P., Demidova T.N., and Hamblin M.R. Mechanism in photodynamic therapy; part three-photosensitizers pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. Photodiagn. Photodyn. Ther. 2 (2005) 91-106
10. Castano A.P., Demidova T.N., and Hamblin M.R. Mechanism in photodynamic therapy; part one-photosensitizers, photochemistry and cellular localization. Photodiagn. Photodyn. Ther. 1 (2004) 279-293
11. Chen H., Chang X., Weng T., Zhao X., Gao Z., Yang Y., Xu H., and Yang X. A study of microemulsion systems for transdermal delivery of triptolide. J. Control. Release 98 (2004) 427-436
12. Chittasupho C., Xie S.X., Baoum A., Yakovleva T., Siahaan T.J., and Berkland C.J. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. Eur. J. Pharm. Sci. 37 (2009) 141-150
13. Cho K., Wang X., Nie S., Chen Z.G., and Shin D.M. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. 14 5 (2008) 1310-1316
14. Chorna I.V., Bilyy R., Datsyuk L.O., and Stoika R.S. Comparative study of human breast carcinoma MCF-7 cells differing in their resistance to doxorubicin: effect of ionizing radiation on apoptosis and TGF-β production. Exp. Oncol. 26 (2004) 111-117
15. Chorna I.V., Datsyuk L.O., and Stoika R.S. Expression of Bax, Bad and bcl-2 proteins under X-radiation effect towards human breast carcinoma MCF-7 cells and their doxorubicin-resistant derivatives. Exp. Oncol. 27 (2005) 196-201
16. Couvreur P., and Vauthier C. Polyalkylcyanoacrylate nanoparticles as a drug carrier, present stage and perspectives. J. Control. Release 17 (1991) 187-197
17. Crescenzi E., Varriale L., Iovino M., Chiaviello A., Veneziani B.M., and Palumbo G. Photodynamic therapy with indocyanine green complements and enhances low-dose cisplatin cytotoxicity in MCF-7 breast cancer cells. Mol. Cancer Ther. 3 (2004) 537-544
18. Delaey E., van Laar F., De Vos D., Kamuhwabwa A., Jacobs P., and de Witte P. A comparative study of the photosensitizing characteristics of some cyanine dyes. J. Photochem. Photobiol. B: Biol. 55 (2000) 27-36
19. Doyle L.A., Yang W., Abruzzo L.V., Krogmann T., Gao Y., Rishi A.K., and Ross D.D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 15665-15670
20. Gasco M.R., and Trotta M. Nanoparticles from microemulsions. Int. J. Pharm. 29 (1986) 267-268
21. Gaumet M., Vargas A., Gurny R., and Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur. J. Pharm. Biopharm. 69 (2008) 1-9
22. Gaumet M., Gurny R., and Delie F. Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size. Eur. J. Pharm. Sci. 36 (2009) 465-473
23. Graf A., Ablinger E., Peters S., Zimmer A., Hook S., and Rades T. Microemulsions containing lecithin and sugar-based surfactants: nanoparticle templates for delivery of proteins and peptides. Int. J. Pharm. 350 (2008) 351-360
24. Graf A., Jack K.S., Whittaker A.K., Hook S.M., and Rades T. Protein delivery using nanoparticles based on microemulsion with different structure types. Eur. J. Pharm. Sci. 33 (2008) 434-444
25. Graf A., Rades T., and Hook S.M. Oral insulin delivery using nanoparticles based on microemulsions with different structure-types: optimization and in vivo evaluation. Eur. J. Pharm. Sci. 37 (2009) 53-61
26. Greish K. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J. Drug Target. 15 (2007) 457-464
27. Guterres S.S., Alves M.P., and Pohlmann A.R. Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications. Drug Target. Insights. 2 (2007) 147-157
28. Huang Z., Xu H., Meyers A.D., Musani A.I., Wang L., Tagg R., Barqawi A.B., and Chen Y.K. Photodynamic therapy for treatment of solid tumors-potential and technical challenges. Technol. Cancer Res. Treat. 7 (2008) 309-320
29. Jain A., and Jain S.K. In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumor. Eur. J. Pharm. Sci. 35 (2009) 404-416
30. Johnston A.P.R., Cortez C., Angelatos A.S., and Caruso F. Layer-by-layer engineered capsules and their applications. Curr. Opin. Colloid Interface Sci. 11 (2006) 203-209
31. Josefsen L.B., and Boyle R.W. Photodynamic therapy: novel third-generation photosensitizers: one step closer. Br. J. Pharmacol. 154 (2008) 1-3
32. Kassab K. Photophysical and photosensitizing properties of selected cyanines. J. Photochem. Photobiol. B: Biol. 68 (2002) 15-22
33. Krauel K., Davies N.M., Hook S., and Rades T. Using different structure types of microemulsions for the preparation of poly(alkyl cyanoacrylate) nanoparticles by interfacial polymerization. J. Control. Release 106 (2005) 76-87
34. Krauel K., Graf A., Hook S.M., Davies N.M., and Rades T. Preparation of poly(alkyl cyanoacrylate) nanoparticles by polymerization of water-free microemulsions. J. Microencapsul. 23 (2006) 499-512
35. Lambert G., Fattal E., Pinto-Alphandary H., Gulik A., and Couvreurr P. Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for delivery of oligonucleotides. Pharm. Res. 17 (2000) 707-714
36. Lawrence M.J., and Rees G.D. Microemulsion-based media as novel drug delivery systems. Adv. Deliv. Rev. 45 (2000) 89-121
37. Leonard F., Kulkarni R.K., Brandes G., Nelson J., and Cameron J.J. Synthesis and degradation of poly(alkyl cyanoacrylates). J. Appl. Polym. Sci. 10 (1966) 259-272
38. Lherm C., Muller R.H., Puisieux F., and Couvreur P. Alkylcyanoacrylate drug carriers. 2. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain-length. Int. J. Pharm. 84 (1992) 13-22
39. Li Y.P., Pei Y.Y., Zhou Z.H., Zhang X.Y., Gu Z.H., Ding J., Zhou J.J., Gao X.J., and Zhu J.H. Stealth polycyanoacrylate nanoparticles as tumor necrosis factor-α carriers: pharmacokinetics and anti-tumor effects. Biol. Pharm. Bull. 24 (2001) 662-665
40. Mohajer G., Lee E.S., and Bae Y.H. Enhanced intercellular retention activity of novel pH sensitive polymeric micelles in wild and multidrug resistant MCF-7 cells. Pharm. Res. 24 (2007) 1618-1627
41. Mosmann T. Rapid colorimetric assay for cellular growth and survival: applications to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
42. Moulik S.P., and Paul B.K. Structure, dynamics and transport properties of microemulsions. Adv. Colloid Interface Sci. 78 (1998) 99-195
43. Moulik R., Mahadik K., and Paradkar A. Development of curcuminoids loaded poly(butyl) cyanoacrylate nanoparticles: physicochemical characterization and stability study. Eur. J. Pharm. Sci. 37 (2009) 395-404
44. Na K., Lee E.S., and Bae Y.H. Adriamycin loaded pullulan acetate/sulfonamide conjugate nanoparticles responding to tumor pH: pH-dependent cell interaction, internalization and cytotoxicity in vitro. J. Control. Release 87 (2003) 3-13
45. Nornoo A.O., Osborne D.W., and Chow D.S.-L. Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis. Int. J. Pharm. 349 (2008) 108-116
46. Pouton C.W. Formulation of self-emulsifying drug delivery systems. Adv. Drug Del. Rev. 25 (1997) 47-58
47. Ricci-Júnior E., and Marchetti J.M. Zinc(II) phtalocyanine loaded PLGA nanoparticles for photodynamic therapy use. Int. J. Pharm. 310 (2006) 187-195
48. ® in photynamic therapy. Folia Biol. (Praha) 54 (2008) 24-29
49. ® in malignant and normal endothelial cell lines. Folia Biol. (Praha) 53 (2007) 7-12
50. Saxena V., Sadoqi M., and Shao J. Enhanced photo-stability, thermal-stability and aqueous-stability of indocyanine green in polymeric nanoparticulate systems. J. Photochem. Photobiol. B: Biol. 74 (2004) 29-38
51. Saxena V., Sadoqi M., and Shao J. Polymeric nanoparticulate delivery system for Indocyanine green: biodistribution in healthy mice. Int. J. Pharm. 308 (2006) 200-204
52. Soule H.D., Vazquez J., Albert S., and Brennan M.J. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51 (1973) 1409-1416
53. Söderlind E., Wollbratt M., and Von Corswant C. The usefulness of sugar surfactants as solubilizing agent in parenteral formulations. Int. J. Pharm. 252 (2003) 61-71
54. Subramanian N., Ghosal S.K., Acharya A., and Moulik S.P. Formulation and physicochemical characterization of microemulsion system using iso-propyl myristate, medium-chain glyceride, polysorbate 80 and water. Chem. Pharm. Bull. 53 (2005) 1530-1535
55. Thadros T.F. Surfactants in pharmaceutical formulations. Applied Surfactants. Principles and Applications (2005), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 433-502
56. Torchilin V.P. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J. 9 (2007) 128-147
57. Vasir J.K., and Labhasetwar V. Biodegradable nanoparticles for cytosolic celivery of therapeutics. Adv. Drug Deliv. Syst. 59 (2007) 718-728
58. Vauthier C., Dubernet C., Chauvierre C., Brigger I., and Couvreur P. Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles. J. Control. Release 93 (2003) 151-160
59. von Rybinski W., and Hill K. Alkyl polyglucosides. In: Holmberg K. (Ed). Novel Surfactants. Preparation, Applications, and Biodegradability (2003), Marcel Dekker, New York 35-94
60. Watnasirichaikul S., Davies N.M., Rades T., and Tucker I.G. Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions. Pharm. Res. 17 (2000) 684-689
61. Watnasirichaikul S., Rades T., Tucker I.G., and Davies N.M. Effects of formulation variables on characteristics of poly(ethyl cyanoacrylate) nanocapsules prepared from w/o microemulsions. Int. J. Pharm. 235 (2000) 237-246
62. Watnasirichaikul S., Rades T., Tucker I.G., and Davies N.M. Effects of formulation variables on characteristics of poly(ethylcyanoacrylate) nanocapsules prepared from w/o microemulsions. Int. J. Pharm. 235 (2002) 237-246
63. Wilk K.A., Zielińska K., Pietkiewicz J., and Saczko J. Loaded nanoparticles with cyanine-type photosensitizers: preparation, characterization and encapsulation. Chem. Eng. Trans. 17 (2009) 987-992
64. Wilk K.A., Zielińska K., Hamerska-Dudra A., and Jezierski A. Biocompatible microemulsions of dicephalic aldonamide-type surfactants: formulation, structure and temperature influence. J. Colloid Interface Sci. 334 (2009) 87-95
65. Yokoyama M. Drug targeting with nano-sized carrier system. J. Artif. Organs. 8 (2005) 77-84
66. Zielińska K., Wilk K.A., Seweryn E., Pietkiewicz J., and Saczko J. Studies on biocompatible nanocapsules formed from microemulsion templated processes. Mater. Sci. Pl. 26 (2008) 443-450
67. Zielińska K., Wilk K.A., Jezierski A., and Jesionowski T. Microstructure and structural transition in microemulsions stabilized by aldonamide-type surfactants. J. Colloid Interface Sci. 321 (2008) 408-417